Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | sphingosine kinase 1 | Starlite/ChEMBL | References |
Homo sapiens | sphingosine kinase 2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | 0.0369 | 0.1287 | 0.5 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.2044 | 1 | 1 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.2044 | 1 | 1 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.2044 | 1 | 1 |
Leishmania major | casein kinase II, putative | 0.087 | 0.3891 | 0.5 |
Loa Loa (eye worm) | CAMK/CAMKL/PASK protein kinase | 0.1042 | 0.479 | 0.4021 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.087 | 0.3891 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.087 | 0.3891 | 0.5 |
Giardia lamblia | Kinase, CMGC CK2 | 0.087 | 0.3891 | 0.5 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.087 | 0.3891 | 0.2989 |
Trichomonas vaginalis | CMGC family protein kinase | 0.087 | 0.3891 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.087 | 0.3891 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.087 | 0.3891 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.087 | 0.3891 | 1 |
Trypanosoma brucei | Casein kinase II | 0.087 | 0.3891 | 1 |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.087 | 0.3891 | 0.2989 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.087 | 0.3891 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.087 | 0.3891 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.087 | 0.3891 | 0.5 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.2044 | 1 | 1 |
Plasmodium vivax | unspecified product | 0.087 | 0.3891 | 0.5 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.2044 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.087 | 0.3891 | 0.5 |
Entamoeba histolytica | casein kinase, putative | 0.087 | 0.3891 | 1 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.087 | 0.3891 | 0.5 |
Trypanosoma cruzi | casein kinase II, putative | 0.087 | 0.3891 | 0.5 |
Schistosoma mansoni | protein kinase | 0.087 | 0.3891 | 0.2989 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2044 | 1 | 1 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.2044 | 1 | 1 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.087 | 0.3891 | 0.2989 |
Mycobacterium tuberculosis | Conserved protein | 0.0369 | 0.1287 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 0.85 uM | Inhibition of SphK1 in human WM266-4 cells assessed as inhibition of formation of [17C]-S1P formation after 20 mins by LC-MS analysis | ChEMBL. | 23845219 |
IC50 (binding) | = 0.13 uM | Inhibition of purified human SphK1 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting | ChEMBL. | 23845219 |
IC50 (binding) | > 5 uM | Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting | ChEMBL. | 23845219 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.